Segall Bryant & Hamill, LLC Anixa Biosciences Inc Transaction History

Segall Bryant & Hamill, LLC

  • $7.16 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$3.78 - $5.81 $65,772 - $101,094
17,400 New
17,400 $73,000
Q3 2022

Nov 14, 2022
BUY
$2.81 - $6.15 $48,894 - $107,010
17,400 New
17,400 $86,000
Q4 2018

Feb 15, 2019
BUY
$3.37 - $6.59 $58,638 - $114,666
17,400 New
17,400 $68,000

Others Institutions Holding ANIX

# of Institutions
60
Shares Held
5.56M
Call Options Held
21K
Put Options Held
6.7K
View Full List

About Anixa Biosciences Inc

ANIX Quotes by TradingView
  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $76M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email